Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

[1]  Y. Tanaka,et al.  Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells. , 1990, Journal of immunology.

[2]  R. Anderson,et al.  The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove. , 1990, International Immunology.

[3]  D. Mattson,et al.  Immunological studies in tropical spastic paraparesis , 1990, Annals of neurology.

[4]  F. Sigaux,et al.  High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. , 1990, Blood.

[5]  J. Berzofsky,et al.  Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells. , 1989, Journal of immunology.

[6]  J. Goedert,et al.  Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.

[7]  B. Haynes,et al.  Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. , 1989, Journal of immunology.

[8]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[9]  M. Maki,et al.  Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing , 1988, Cell.

[10]  M. Hatanaka,et al.  Processing of gag precursor polyprotein of human T-cell leukemia virus type I by virus-encoded protease , 1988, Journal of virology.

[11]  D. McFarlin,et al.  Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis , 1988, Nature.

[12]  S. Yashiki,et al.  HLA haplotype‐linked high immune responsiveness against HTLV‐I in HTLV‐I‐associated myelopathy: Comparison with adult T‐cell leukemia/lymphoma , 1988, Annals of neurology.

[13]  M. Hatanaka,et al.  Effect of the recombinant vaccinia viruses that express HTLV‐I envelope gene on HTLV‐I infection. , 1987, The EMBO journal.

[14]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[15]  R. Gallo,et al.  Human T-lymphotropic retroviruses , 1985, Nature.

[16]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[17]  W. Blattner,et al.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. , 1984, The Journal of clinical investigation.

[18]  P. Bunn,et al.  Generation of an HLA-restricted cytotoxic T cell line reactive against cultured tumor cells from a patient infected with human T cell leukemia/lymphoma virus , 1983, The Journal of experimental medicine.

[19]  B. Fleischer,et al.  Clonal expansion and functional analysis of virus-specific T lymphocytes from cerebrospinal fluid in measles encephalitis. , 1983, Human immunology.

[20]  K. Sugamura,et al.  Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. , 1983, Journal of immunology.

[21]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.